Features of macrophage differentiation induced by p19(INK4d), a specific inhibitor of cyclin D-dependent kinases

Blood

Volumn 90, Issue 1, 1997, Pages 126-137

  Adachi, Masashi ^a   Roussel, Martine F ^a   Havenith, Karin ^a   Sherr, Charles J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; ONCOPROTEIN;

ARTICLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL SURVIVAL; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL;

EID: 0030908849     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.126     Document Type: Article

References (80)

1. Nurse P: Universal control mechanism regulating onset of M-phase. Nature 344:503, 1990
2. Sherr CJ: Mammalian G1 cyclins. Cell 73:1059, 1993
3. Sherr CJ: G1 phase progression: Cycling on cue. Cell 79:551, 1994
4. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81:323, 1995
5. Nevins JR: E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424, 1992
6. La Thangue NB: DRTF1/E2F: An expanding family of heterodimeric transcription factors implicated in cell cycle control. Trends Biochem Sci 19:108, 1994
7. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA: Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91:709, 1994
8. Hatakeyama M, Brill JA, Fink GR, Weinberg RA: Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev 8:1759, 1994
9. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M: Human cyclin E, a nuclear protein essential for the G1 to S phase transition. Mol Cell Biol 15:2612, 1995
10. Pardee AB: G1 events and regulation of cell proliferation. Science 246:603, 1989
11. Sherr CJ: Cancer cell cycles. Science 274:1672, 1996
12. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7:812, 1993
13. 1, phase in rodent fibroblasts. Genes Dev 7:1559, 1993
14. Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J: Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells, independent of CDK4 activity. Mol Cell Biol 15:2600, 1995
15. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ: Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701, 1991
16. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk4. Nature 366:704, 1993
17. INK4b is a potential effector of cell cycle arrest mediated by TGF-β. Nature 371:257, 1994
18. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8:2939, 1994
19. Hirai H, Roussel MF, Kato J, Ashmun RA, Sherr CJ: Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15:2672, 1995
20. ink4. Mol Cell Biol 15:2682, 1995
21. CDKN2 tumour suppressor. Nature 375:503, 1995
22. Koh J, Enders GH, Dynlacht BD, Harlow E: Tumour-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature 375:506, 1995
23. INK4. Science 267:249, 1995
24. ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92:6289, 1995
25. Reynisdóttir I, Polyak K, lavarone A, Massagué J: Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 9:1831, 1995
26. Ando K, Ajchenbaum-Cymbalista F, Griffin JD: Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells. Proc Nat Acad Sci USA 90:9571, 1993
27. Kato J, Sherr CJ: Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc Natl Acad Sci USA 90:11513, 1993
28. Greenberger JS, Sakakeeny MA, Humphries RJ, Eaves CJ, Eckner RJ: Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 80:2931, 1983
29. Valtieri M, Tweardy DJ, Caracciolo D, Johnson K, Mavilio F, Altmann S, Santoli D, Rovera G: Cytokine-dependent granulocytic differentiation. J Immunol 138:3829, 1987
30. Inaba T, Inukai T, Yoshihara T, Seyschab H, Ashmun RA, Canman CE, Laken SJ, Kastan MB, Look AT: Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Nature 382:541, 1996
31. Kato JY, Sherr CJ: Human colony-stimulating factor 1 (CSF-1) receptor confers CSF-1 responsiveness to interleukin-3-dependent 32DCL3 mouse myeloid cells and abrogates differentiation in response to granulocyte CSF. Blood 75:1780, 1990
32. Downing JR, Rettenmier CW, Sherr CJ: Ligand-induced tyrosine kinase activity of the colony stimulating factor-1 receptor in a murine macrophage cell line. Mol Cell Biol 8:1795, 1988
33. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase, CDK4. Genes Dev 7:331, 1993
34. Vallance SJ, Lee H, Roussel MF, Shurtleff SA, Kato J, Strom DK, Sherr CJ: Monoclonal antibodies to mammalian D-type G1 cyclins. Hybridoma 13:37, 1993
35. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato J: D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066, 1994
36. Meyerson M, Harlow E: Identification of a G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 14:2077, 1994
37. PSKJ3/CDK4) for mammalian D-type G1 cyclins. Cell 71:323, 1992
38. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM: Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487, 1993
39. Morgan C, Pollard JW, Stanley ER: Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5. J Cell Physiol 130:420, 1987
40. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER: The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665, 1985
41. Furman WL, Rettenmier CW, Chen JH, Roussel MF, Quinn CO, Sherr CJ: Antibodies to distal carboxyl terminal epitopes in the v-fms-coded glycoprotein do not cross-react with the c-fms gene product. Virology 152:432, 1986
42. Ashmun RA, Look AT, Roberts WM, Roussel MF, Seremetis S, Ohtsuka M, Sherr CJ: Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells. Blood 73:827, 1989
43. Rettenmier CW, Roussel MF, Kitchingman GR, Look AT, Sherr CJ: Transmembrane orientation of glycoproteins encoded by the v-fms oncogene. Cell 40:971, 1985
44. Rothwell VM, Rohrschneider LR: Murine c-fms cDNA: Cloning, sequence analysis, and retroviral expression. Oncogene Res 1:311, 1987
45. Pearse AGE: Histochemistry, Theoretical and Applied. Edinburgh, UK, Churchill Livingstone, 1968
46. Vlaanderen K, Bos HJ, Fijter CWH, Oe LP, Verbrugh HA, Beelen RHJ: Short dwell times reduce the local defense mechanism of chronic peritoneal dialysis patients. Nephron 57:29, 1991
47. Roussel MF, Rettenmier CW, Look AT, Sherr CJ: Cell surface expression of v-fms coded glycoproteins is required for transformation. Mol Cell Biol 4:1999, 1984
48. Resnitzky D, Gossen M, Bujard H, Reed SI: Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669, 1994
49. Springer T, Galfre G, Sacher DS, Milstein C: MAC1: A macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 9:301, 1979
50. Ralph P, Ho M-K, Litcofsky PB, Springer TA: Expression and induction in vitro of macrophage differentiation antigens on murine cell lines. J Immunol 130:108, 1983
51. Nasu N, Yoshida S, Akizuki S, Higuchi Y, Setoguchi M, Yamamoto S: Molecular and physiological properties of murine CD14. Int Immunol 3:205, 1991
52. Austyn JM, Gordon S: F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11:805, 1981
53. Rohrschneider LR, Metcalf D: Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells. Mol Cell Biol 9:5081, 1989
54. Pierce JH, Di Marco E, Cox GW, Lombardi D, Ruggiero M, Varesio L, Wang LM, Choudhury GG, Sakaguchi AY, Di Fiore PP, Aaronson SA: Macrophage colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/ CSF-1 receptor cDNA. Proc Natl Acad Sci USA 87:5613, 1990
55. Guilbert LJ, Stanley ER: Specific interaction of murine colony-stimulating factor with mononuclear phagocytic cells. J Cell Biol 85:153, 1980
56. Byrne PV, Guilbert LJ, Stanley ER: Distribution of cells bearing receptors for a colony-stimulating factor (CSF-1) in murine tissues. J Cell Biol 91:848, 1981
57. 125I-colony-stimulating factor-1 with bone marrow-derived macrophages. J Biol Chem 261:4024, 1986
58. Sherr CJ: Colony-stimulating factor-1 receptor. Blood 75:1, 1990
59. Kato JY, Roussel MF, Ashmun RA, Sherr CJ: Transduction of human colony stimulating factor-1 receptor into interleukin-3-dependent mouse myeloid cells induces both CSF-1-dependent and factor-independent growth. Mol Cell Biol 9:4069, 1989
60. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149, 1995
61. Jiang H, Lin J, Su Z, Collart FR, Huberman E, Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397, 1994
62. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME: Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389, 1994
63. CIP1 in muscle and other terminally differentiating cells. Science 267:1024, 1995
64. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lasser AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018, 1995
65. Rao SS, Chu C, Kohtz DS: Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helixloop-helix regulators. Mol Cell Biol 14:5259, 1994
66. Skapek SX, Rhee J, Spicer DB, Lassar AB: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D-dependent kinase. Science 267:1022, 1995
67. CIP1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650, 1995
68. ink4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol Biol Cell 7:1587, 1996
69. Cip1/Waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675, 1995
70. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27, 1996
71. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ: Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552, 1995
72. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707, 1996
73. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A: Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 85:721, 1996
74. Kip1-deficient mice. Cell 85:733, 1996
75. Ohtsubo M, Roberts JM: Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908, 1993
76. Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877, 1996
77. Kip1 by cDNA antisense suppresses quiescence (GO) state in fibroblasts. J Biol Chem 271:18337, 1996
78. Liu M, Lee M-H, Cohen M, Bommakanti M, Freedman LP: Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142, 1996
79. Krishnaraju K, Nguyen HG, Liebermann DA, Hoffman B: The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells. Mol Cell Biol 15:5499, 1995
80. Hirai H, Sherr CJ: Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1. Mol Cell Biol 16:6457, 1996